Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Ferulate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 known ✓ | P09917 | 2/20 | 0.74 |
| ▸ | CA12 known ✓ | O43570 | 2/20 | 0.72 |
| ▸ | CA1 known ✓ | P00915 | 2/20 | 0.72 |
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.72 |
| ▸ | CA4 known ✓ | P22748 | 2/20 | 0.72 |
| ▸ | PTGS1 known ✓ | P23219 | 2/20 | 0.70 |
| ▸ | PTGS2 known ✓ | P35354 | 2/20 | 0.70 |
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.70 |
| ▸ | TLR9 known ✓ | Q9NR96 | 1/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.74 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.74 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.74 |
| ▸ | STAT3 | P40763 | 2/20 | 0.74 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.74 |
| ▸ | RELA | Q04206 | 2/20 | 0.74 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.74 |
| ▸ | APP | P05067 | 4/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.72 |
| ▸ | CA3 | P07451 | 2/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ferulate SCHEMBL30241498 | 1.00 | CYP2D6 (0.74) | CYP2D6NFKB1CYP1A2ALOX5HSD11B1 | |
| Ferulate SCHEMBL31527467 | 1.00 | CYP2D6 (0.74) | CYP2D6NFKB1CYP1A2ALOX5HSD11B1 | |
| Ferulate SCHEMBL81855 | 1.00 | CYP2D6 (0.74) | CYP2D6NFKB1CYP1A2ALOX5HSD11B1 | |
| Ferulate SCHEMBL31534808 | 1.00 | CYP2D6 (0.74) | CYP2D6NFKB1CYP1A2ALOX5HSD11B1 | |
| Ferulate SCHEMBL28324764 | 0.98 | CYP2D6 (0.72) | CYP2D6NFKB1CYP1A2ALOX5HSD11B1 | |
| Ferulate SCHEMBL27592994 | 0.98 | CYP2D6 (0.72) | CYP2D6NFKB1CYP1A2ALOX5HSD11B1 | |
| Ferulate SCHEMBL28675975 | 0.98 | CYP2D6 (0.72) | CYP2D6NFKB1CYP1A2ALOX5HSD11B1 | |
| Ferulate SCHEMBL20546258 | 0.98 | CYP2D6 (0.77) | CYP2D6NFKB1CYP1A2ALOX5HSD11B1 | |
| Ferulate SCHEMBL22207956 | 0.98 | CYP2D6 (0.77) | CYP2D6NFKB1CYP1A2ALOX5HSD11B1 | |
| Ferulate SCHEMBL22206814 | 0.97 | CYP2D6 (0.74) | CYP2D6NFKB1CYP1A2ALOX5HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2178 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122074540-A | Rosemary serving as preservative and extraction process thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-20260102359-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA LLC (US) | 2026-04-16 | — | — | US | claimed |
| EP-4593859-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | Eresina, LLC (US) | 2025-08-06 | — | — | EP | claimed |
| CN-120188780-A | Stem cell combined protective liquid and preparation method and application thereof | 北京益华生物科技有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119970707-A | Application of salvianolic acid A in preparation of medicines for preventing and treating advanced atherosclerosis vulnerable plaque | 山东中医药大学 | 2025-05-13 | — | — | CN | claimed |
| WO-2025086123-A1 | ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS | L'OREAL (FR) | 2025-05-01 | — | — | WO | claimed |
| CN-119040153-A | Candida elvata strain for producing 4-vinyl guaiacol and application thereof | 天津科技大学 | 2024-11-29 | — | — | CN | claimed |
| CN-118831031-A | Rhizoma bletillae fresh pulp nanofiber dry mask and preparation method thereof | 成都中医药大学 | 2024-10-25 | — | — | CN | claimed |
| CN-107049232-B | Attached heart function monitoring and/or intervention system | 周晓辉 | 2024-04-16 | — | — | CN | claimed |
| WO-2024073011-A1 | TOPICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA, LLC (US) | 2024-04-04 | — | — | WO | claimed |
| CN-1273093-A | Hypoglycemix Xinxuekang and itspreparing process | XIN YAOLU (CN) | 2000-11-15 | — | — | CN | claimed |
| EP-0979039-A4 | METHOD OF CONTROLLING RELEASE OF BITTERNESS INHIBITORS IN CHEWING GUM AND GUM PRODUCED THEREBY | WRIGLEY W M JUN CO (US) | 2000-04-12 | — | — | EP | claimed |
| EP-0979039-A1 | METHOD OF CONTROLLING RELEASE OF BITTERNESS INHIBITORS IN CHEWING GUM AND GUM PRODUCED THEREBY | WM. WRIGLEY JR. COMPANY (US) | 2000-02-16 | — | — | EP | claimed |
| CN-1225354-A | Water separation method for preparing sodium ferulate and sterol using ferulaic acid or ferulate | CHU YUANPENG (CN) | 1999-08-11 | — | — | CN | claimed |
| WO-1998023166-A1 | METHOD OF CONTROLLING RELEASE OF BITTERNESS INHIBITORS IN CHEWING GUM AND GUM PRODUCED THEREBY | WM. WRIGLEY JR. COMPANY (US) | 1998-06-04 | — | — | WO | claimed |
| EP-0633021-B1 | Chondroprotective agents | KUREHA CHEMICAL IND CO LTD (JP) | 1998-05-06 | — | — | EP | claimed |
| CN-1034328-C | Method for preparation of ferulic acid, sodium ferulate, sterol from ferulic acid ester | CAI KEZHONG (CN) | 1997-03-26 | — | — | CN | claimed |
| CN-1100631-A | Chondroprotective agents | KUREHA CHEMICAL IND CO LTD (JP) | 1995-03-29 | — | — | CN | claimed |
| EP-0633021-A1 | Chondroprotective agents | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-01-11 | — | — | EP | claimed |
| CN-1093698-A | A kind of method for preparing forulic acid, Sodium Ferulate, sterol from ferulic acid ester | CAI KEZHONG (CN) | 1994-10-19 | — | — | CN | claimed |